| Literature DB >> 34452449 |
Anastasia Treshchalina1, Yulia Postnikova2, Elizaveta Boravleva1, Alexandra Gambaryan1, Alla Belyakova1, Aydar Ishmukhametov1, Galina Sadykova3, Alexey Prilipov3, Natalia Lomakina3.
Abstract
The H7 subtype of avian influenza viruses (AIV) stands out among other AIV. The H7 viruses circulate in ducks, poultry and equines and have repeatedly caused outbreaks of disease in humans. The laboratory strain A/chicken/Rostock/R0p/1934 (H7N1) (R0p), which was previously derived from the highly pathogenic strain A/FPV/Rostock/1934 (H7N1), was studied in this work to ascertain its biological property, genome stability and virulent changing mechanism. Several virus variants were obtained by serial passages in the chicken lungs. After 10 passages of this virus through the chicken lungs we obtained a much more pathogenic variant than the starting R0p. The study of intermediate passages showed a sharp increase in pathogenicity between the fifth and sixth passage. By cloning these variants, a pair of strains (R5p and R6p) was obtained, and the complete genomes of these strains were sequenced. Single amino acid substitution was revealed, namely reversion Gly140Arg in HA1. This amino acid is located at the head part of the hemagglutinin, adjacent to the receptor-binding site. In addition to the increased pathogenicity in chicken and mice, R6p differs from R5p in the shape of foci in cell culture and an increased affinity for a negatively charged receptor analogue, while maintaining a pattern of receptor-binding specificity and the pH of conformational change of HA.Entities:
Keywords: highly pathogenic avian influenza viruses; pathogenicity factors
Mesh:
Substances:
Year: 2021 PMID: 34452449 PMCID: PMC8402889 DOI: 10.3390/v13081584
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Mutations emerging during serial passages of the R0p through chicken lungs.
| Protein | PB2 | PB2 | PB1 | PB1-F2 | PA | HA1 | HA2 | M2 | NS1 | NS1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Position * | 109 | 567 | 621 | 4 | 32 | 140 | 101 | 82 | 112 | 118 |
| 0 passages | Val | Val | Gln | Glu | Trp | Gly | Ala | Ser | Arg | Met |
| 5 passages | Phe | Ala | Lys | Glu | Ala | Gly | Thr | Ser | Arg | Arg |
| 6 passages | Phe | Ala | Lys | Glu | Ala | Arg | Thr | Ser | Arg | Arg |
| 10 passages | Phe | Ala | Lys | Gly | Ala | Arg | Thr | Arg | Lys | Arg |
* HA amino acids are numbered according to H3.
Figure 1Arg140 arrangement in HA. Atomic coordinates of H7 HA (1ti8) were used [24]. (A) The protein surface is colored blue. The key amino acids of RBS are colored red. The Arg140 is colored by element. (B) Protein chain of HA near the RBS. The key amino acids of RBS are colored red and marked. The Arg140 and neighboring amino acids are colored by element.
Survival of one-week-old and eight-week-old chicks after infection with the passage variants of the virus R0p.
| Chick Age | One-Week-Old Chicks | Eight-Week-Old Chicks | |||
|---|---|---|---|---|---|
| Variants | Designation | Infected | Survived | Infected | Survived |
| m/Sw/91/02 * | H7N9 | 6 | 6 | 2 | 2 |
| ch/Ku/5/05 * | H5N1 | 5 | 0 | 5 | 0 |
| 0 passages | R0p | 4 | 3 | 5 | 5 |
| 1 * passage | R1p | 3 | 1 | 2 | 2 |
| 2 passages | R2p | 3 | 2 | 2 | 2 |
| 3 passages | R3p | 3 | 3 | 6 | 6 |
| 4 passages | R4p | 2 | 2 | 2 | 2 |
| 5 passages | R5p | 2 | 2 | 2 | 2 |
| 6 passages | R6p | 5 | 0 | 15 | 0 |
| 7 passages | R7p | 2 | 0 | ||
| 8 passages | R8p | 2 | 0 | ||
| 9 passages | R9p | 2 | 0 | ||
| 10 passages | R10p | 2 | 0 | 6 | 0 |
* The data on the low pathogenic virus A/mallard/Sweden/91/02 (H7N9) (m/Sw/91/02) and the highly pathogenic virus A/chicken/Kurgan/5/2005 (H5N1) (ch/Ku/5/05) are given for comparison.
Figure 2Antibodies against homologous virus measured in ELISA in serum of mice infected with 101 EID50 of R5p. Blue curves show levels of signal for 6 infected mice. Red curves show levels of signal for 2 non-infected mice. The first point in all curves shows signals in control well (column H without virus, see Section 2.13).
Effect of Gly140Arg amino acid substitution in HA1 on pathogenicity in mice.
| Virus | Cleavage Site of HA | a.a. in 140 HA1 | Immunogenic Dose (ImD50) | Disease Dose (DD50) | Lethal Dose (LD50) |
|---|---|---|---|---|---|
| R5p |
| Gly | ≤1 | 4 | 5 |
| R6p |
| Arg | ≤1 | 3 | 4 |
| m/Sw/91/02 |
| Arg | ≤4 | >6 | >6 |
| ch/Ku/5/05 |
| Pro | ≤0.3 | 0.3 | 0.3 |
Figure 3Weight dynamics and survival of mice infected with R5p, R6p and the A/mallard/Sweden/91/02 (H7N9) virus. Result of a typical experiment is presented.
Figure 4The pH dependence of erythrocyte hemolysis in complex with R5p and R6p viruses. A415—absorption at 415 nm, which corresponds to the degree of erythrocyte hemolysis. Result of a typical experiment is presented.
Figure 5Affinity of peroxidase-labeled fetuin for virions of R5p and R6p strains. The results of testing Fet-HRP on a plate coated with R5p and R6p viruses are presented in Scatchard coordinates. The X-axis is the A450 signal reflecting the amount of bound fetuin, and the Y-axis is the ratio of the A450 signal to the fetuin concentration (expressed in µM of sialic acid) in the solution. Result of a typical experiment is presented.
Sialyloligosaccharide and designation of the oligosaccharide moieties.
| Sialyloligosaccharide | Designation |
|---|---|
| Neu5Acα2-6Galβ1-4GlcNAcβ- | 6’SLN |
| Neu5Acα2-3Galβ1-4Glcβ- | 3’SL |
| Neu5Acα2-3Galβ1-4GlcNAcβ- | 3’SLN |
| Neu5Acα2-3Galβ1-4-(6-O-Su)GlcNAcβ- | Su3’SLN |
| Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ- | SLex |
| Neu5Acα2-3Galβ1-3GlcNAcβ- | SLec |
| Neu5Acα2-3Galβ1-3(Fucα1-4)GlcNAcβ- | SLea |
| Neu5Acα2-3Galβ1-3GalNAcα- | STF |
| Neu5Acα2-3Galβ1-3-(6-Su)GalNAcα- | SuSTF |
Figure 6Inhibition of labeled fetuin binding to R5p and R6p viruses by the receptor analogs. Receptor analogs were added to a solution of labeled fetuin at the indicated concentrations and the level of binding of the label to the virus was measured. Result of a typical experiment is presented.
Figure 7Different pictures of cells infected with R5p (A) and R6p (B) variants of influenza virus Rostock.